Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 15

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 15
---
 a maximum amount of CHF [•] through the issuance of not more than [•] registered shares (Common Shares), with a nominal value of CHF 0.03 each by the exercise of option rights which are granted to new shareholder in connection with the a public offer of the Company and the listing of the shares or which are granted instead of shares in case of existing voting rights limitations. […]” 7. Amendment to the Articles to Change the Company’s Name Explanation:In connection with the Merger, the Company’s name is intended to be changed to NUCELX AG. The Company’s shares are intended to continue to be traded on Nasdaq under the ticker symbol NCEL. Proposal:The Board of Directors proposes that the Company’s name shall be changed and that Article 1 (Name, Domicile, Duration) shall be amended as follows: “Art. 1 — Name, Domicile, Duration Incorporated under the name NUCELX AG NUCELX SA NUCELX Ltd. is a stock corporation pursuant to these articles of association and to article 620 et seqq. of the Swiss Code of Obligations, formed for an indefinite duration and having its registered office in Kloten.” 8.Election of the new Board of Directors Explanation:Pursuant to the Merger Agreement, the current members of the Board of Directors (excluding Alexander Zwyer and Olivier Samuel) must resign from their positions immediately prior to the Effective Time. A new Board of Directors, as designated by Kadimastem, shall be elected. The proposed members are: Mr. Ronen Twito:Mr.Ronen Twito, has served as Kadimastem’s Executive Charmian of the Board of Director since December 2020 and its Chief Executive Officer since December 2024. Mr.Twito brings over two decades of executive leadership experience in the biotech and high -techsectors, across both Nasdaq and TASE listed companies. Mr.Twito also served as the Chairman of the board of Bubbles Intergroup Ltd (TASE: “BBLS”) since January 2022. From March 2019 until August 2021, he served as an Independent Director at Mer Telemanagement Solutions Ltd. (Nasdaq: “MTSL”). From November 2015 to March 2017 Mr.Ronen Twito served as Deputy Chief Executive Officer and CFO at Cellect Biotechnology Ltd. (Nasdaq: “APOP”). From May 2014 until November 201